Sparfloxacin Tablet
Generic Name |
Sparfloxacin |
---|---|
Strength |
100 mg, 200 mg, 400 mg |
Form |
Tablet |
Packaging |
1 X 6 Tablet |
Therapeutic use |
Bacterial Infections, Pneumonia, Urinary tract infections |
Manufacturing Period |
30 to 45 Days |
Available Composition of
Name | Strength | Therapeutic use | View More |
---|---|---|---|
Sparfloxacin Tablet | 100 mg, 200 mg, 400 mg | Bacterial Infections, Pneumonia, Urinary tract infections |
Product Description For Sparfloxacin Tablet
products details and uses
Sparfloxacin Tablet Exporter India, Manufacturer and Global Supplier
Sparfloxacin Tablet is a potent fluoroquinolone antibiotic widely prescribed for the treatment of respiratory, urinary, and skin infections caused by susceptible bacteria. As a leading Sparfloxacin Tablet Exporter India, we supply high-quality formulations manufactured under WHO-GMP and ISO-certified facilities. Our products are trusted globally for their safety, efficacy, and adherence to international pharmacopeia standards.
Product Overview
Sparfloxacin belongs to the fluoroquinolone class of antibiotics and works by inhibiting bacterial DNA gyrase and topoisomerase IV enzymes. This action prevents bacterial replication and effectively eliminates the infection. It is especially effective against Gram-positive and Gram-negative bacteria and is prescribed for complicated infections where other antibiotics may not suffice.
As a reputed Sparfloxacin Tablet Exporter India, we ensure that each batch undergoes rigorous quality control tests and is packaged securely to maintain stability during storage and international shipment.
Key Uses of Sparfloxacin Tablet
-
Treatment of respiratory tract infections such as pneumonia, bronchitis, and sinusitis
-
Management of urinary tract infections (UTIs)
-
Treatment of skin and soft tissue infections
-
Effective in sexually transmitted infections caused by susceptible bacteria
-
Prescribed for typhoid and paratyphoid fever in specific cases
-
Used in cases of multidrug-resistant bacterial infections under medical supervision
Precautions to Follow
Patients should use Sparfloxacin Tablets strictly under medical guidance. Important precautions include:
-
Take the tablet as prescribed without skipping doses
-
Inform the doctor of any history of kidney, liver, or heart conditions
-
Avoid use in patients allergic to fluoroquinolones
-
Not recommended during pregnancy or breastfeeding unless advised by a healthcare professional
-
Avoid excessive sun exposure during treatment, as it may increase photosensitivity
-
Complete the full course of medication to prevent antibiotic resistance
As a responsible Sparfloxacin Tablet Exporter India, we provide comprehensive regulatory documents, product information, and safety guidelines to our international clients.
Possible Side Effects
Sparfloxacin Tablet is generally well-tolerated, but some patients may experience:
-
Nausea, vomiting, or diarrhea
-
Abdominal discomfort
-
Dizziness or headache
-
Mild skin rash or itching
-
Photosensitivity reactions
-
Rarely, tendonitis or tendon rupture, especially in elderly patients
Any severe or persistent side effects should be reported to a healthcare professional immediately.
Why Choose Us as Your Sparfloxacin Tablet Exporter India?
-
WHO-GMP and ISO-certified manufacturing units
-
High-quality formulations with strict quality control
-
Compliance with international pharmacopeia standards (IP/BP/USP)
-
Custom packaging and labeling solutions to meet client requirements
-
Competitive pricing with assured on-time delivery
-
Strong global presence in Asia, Africa, Middle East, and Latin America
As a trusted Sparfloxacin Tablet Exporter India, we supply reliable pharmaceutical solutions to hospitals, distributors, NGOs, and government tenders worldwide.
Global Distribution Network
With a strong logistics and compliance framework, we successfully export to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey.